NASDAQ:ZURA Zura Bio (ZURA) Stock Forecast, Price & News $6.60 -0.23 (-3.37%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$6.58▼$7.0250-Day Range$5.75▼$7.0352-Week Range$4.87▼$37.55Volume123,761 shsAverage Volume374,812 shsMarket Capitalization$284.39 millionP/E RatioN/ADividend YieldN/APrice Target$18.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Zura Bio MarketRank™ ForecastAnalyst RatingBuy3.25 Rating ScoreUpside/Downside176.5% Upside$18.25 Price TargetShort InterestHealthy0.77% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.27) to ($0.87) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.12 out of 5 starsMedical Sector466th out of 964 stocksBiological Products, Except Diagnostic Industry69th out of 158 stocks 3.6 Analyst's Opinion Consensus RatingZura Bio has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.25, Zura Bio has a forecasted upside of 176.5% from its current price of $6.60.Amount of Analyst CoverageZura Bio has only been the subject of 3 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.77% of the float of Zura Bio has been sold short.Short Interest Ratio / Days to CoverZura Bio has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Zura Bio has recently decreased by 7.15%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldZura Bio does not currently pay a dividend.Dividend GrowthZura Bio does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ZURA. Previous Next 1.1 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for Zura Bio this week, compared to 2 articles on an average week.Search Interest6 people have searched for ZURA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows4 people have added Zura Bio to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Zura Bio insiders have not sold or bought any company stock.Percentage Held by Insiders15.80% of the stock of Zura Bio is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Zura Bio are expected to grow in the coming year, from ($2.27) to ($0.87) per share. Previous Next See Top Rated MarketRank™ Stocks Here About Zura Bio (NASDAQ:ZURA) StockZura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.Read More ZURA Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZURA Stock News HeadlinesSeptember 26, 2023 | americanbankingnews.comZura Bio (NASDAQ:ZURA) Trading Up 6.7%September 12, 2023 | finance.yahoo.comZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)U.S. drive to onshore battery supply chains could create big winners in lithiumInvestor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsSeptember 7, 2023 | barrons.comZura Bio Ltd. WtSeptember 7, 2023 | finance.yahoo.comWe're Hopeful That Zura Bio (NASDAQ:ZURA) Will Use Its Cash WiselyAugust 25, 2023 | msn.comOppenheimer starts Zura Bio at outperform, cites potential of ZB-106August 25, 2023 | msn.comOppenheimer Initiates Coverage of Zura Bio Ltd - (ZURA) with Outperform RecommendationAugust 15, 2023 | msn.comRaymond James Maintains Zura Bio Ltd - (ZURA) Strong Buy RecommendationSeptember 26, 2023 | Micro-Cap Stock Trader (Ad)U.S. drive to onshore battery supply chains could create big winners in lithiumInvestor Find Lithium Gold and Crush the Bear Market with 32k Metric TonsAugust 15, 2023 | markets.businessinsider.comWhere Zura Bio Stands With AnalystsAugust 14, 2023 | finance.yahoo.comZura Bio Reports Second Quarter 2023 Financial Results and Recent Business HighlightsJuly 20, 2023 | seekingalpha.comZURAW Zura Bio Limited WT EXP 032028June 23, 2023 | benzinga.comZura Bio shares are trading lower Wednesday amid possible profit-taking after the stock rallied on Tuesday.June 23, 2023 | seekingalpha.comZura Bio to join Russell 2000 and Russell 3000 indexesJune 23, 2023 | benzinga.comZura Bio shares are trading higher after the company announced it will join the Russell 2000 and Russell 3000 indexes.June 22, 2023 | seekingalpha.comZura Bio a new buy at Guggenheim on immunology, inflammation assetsJune 22, 2023 | investing.comZura Bio Ltd (94E)June 21, 2023 | fool.comZura Bio (NASDAQ: ZURA)June 21, 2023 | markets.businessinsider.comWhat's Going On With Zura Bio Stock TodayJune 20, 2023 | fool.comWhy Shares of Zura Bio Climbed TuesdayJune 14, 2023 | benzinga.comChardan Capital Initiates Coverage On Zura Bio with Buy Rating, Announces Price Target of $14June 6, 2023 | investorplace.comWhy Is Zura Bio (ZURA) Stock Up 9% Today?June 6, 2023 | msn.comGitLab, Hello Group, Sprinklr, And Other Big Stocks Moving Higher In Tuesday's Pre-Market SessionJune 6, 2023 | marketwatch.comZura Shares Jump After $80 Million Private Placement ClosesJune 6, 2023 | finance.yahoo.comZura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual AntagonistJune 6, 2023 | msn.comZura Bio climbs 7% as director buys stockMay 24, 2023 | benzinga.comZura Bio shares are trading higher after Raymond James initiated coverage on the stock with a Strong Buy rating and a $20 price target.See More Headlines Receive ZURA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zura Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address ZURA Company Calendar Last Earnings8/14/2023Today9/26/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ZURA CUSIPN/A CIK1855644 WebN/A Phone858-247-0520FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Forecast$18.25 High Stock Price Forecast$22.00 Low Stock Price Forecast$14.00 Forecasted Upside/Downside+172.4%Consensus RatingBuy Rating Score (0-4)3.25 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.55 million Net MarginsN/A Pretax MarginN/A Return on Equity-110.19% Return on Assets-28.68% Debt Debt-to-Equity RatioN/A Current Ratio5.68 Quick Ratio5.68 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$1.08 per share Price / Cash Flow6.22 Book Value($2.21) per share Price / Book-3.03Miscellaneous Outstanding Shares43,090,000Free Float36,285,000Market Cap$288.70 million OptionableNot Optionable Beta0.45 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. David BradyHead of Bus. Devel.Dr. Someit Sidhu M.D. (Age 34)CEO & Director Mr. Verender S. Badial (Age 51)Chief Financial Officer Dr. Gary Whale (Age 49)Chief Technology Officer Dr. Michael D. Howell Ph.D. (Age 46)Chief Scientific Officer & Head of Translational Science Ms. Kimberly Ann Davis (Age 55)Chief Legal Officer & Sec. Ms. Theresa Lowry (Age 49)Chief HR Officer Dr. Christopher H. Cabell FACC (Age 54)M.D., MHS, Chief Medical Officer, Exec. VP and Head of R&D More ExecutivesKey CompetitorsAlloVirNASDAQ:ALVRCompass TherapeuticsNASDAQ:CMPXVigil NeuroscienceNASDAQ:VIGLFate TherapeuticsNASDAQ:FATESutro BiopharmaNASDAQ:STROView All CompetitorsInsiders & InstitutionsSuvretta Capital Management LLCBought 2,850,000 shares on 8/15/2023Ownership: 10.536%Citadel Advisors LLCBought 712,905 shares on 8/15/2023Ownership: 2.636%Point72 Asset Management L.P.Bought 469,277 shares on 8/15/2023Ownership: 1.735%Silverarc Capital Management LLCBought 160,000 shares on 8/15/2023Ownership: 0.591%Alliancebernstein L.P.Bought 23,400 shares on 8/15/2023Ownership: 0.087%View All Insider TransactionsView All Institutional Transactions ZURA Stock - Frequently Asked Questions Should I buy or sell Zura Bio stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zura Bio in the last twelve months. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ZURA shares. View ZURA analyst ratings or view top-rated stocks. What is Zura Bio's stock price forecast for 2023? 4 Wall Street research analysts have issued 12 month price objectives for Zura Bio's shares. Their ZURA share price forecasts range from $14.00 to $22.00. On average, they anticipate the company's share price to reach $18.25 in the next year. This suggests a possible upside of 172.4% from the stock's current price. View analysts price targets for ZURA or view top-rated stocks among Wall Street analysts. How have ZURA shares performed in 2023? Zura Bio's stock was trading at $29.42 at the beginning of 2023. Since then, ZURA shares have decreased by 77.2% and is now trading at $6.70. View the best growth stocks for 2023 here. When is Zura Bio's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our ZURA earnings forecast. How were Zura Bio's earnings last quarter? Zura Bio Limited (NASDAQ:ZURA) released its quarterly earnings results on Monday, August, 14th. The company reported ($1.31) earnings per share for the quarter, missing analysts' consensus estimates of ($0.25) by $1.06. What is Zura Bio's stock symbol? Zura Bio trades on the NASDAQ under the ticker symbol "ZURA." Who are Zura Bio's major shareholders? Zura Bio's stock is owned by a number of institutional and retail investors. Top institutional investors include Great Point Partners LLC (12.18%), Suvretta Capital Management LLC (10.54%), Deep Track Capital LP (5.86%), Citadel Advisors LLC (2.64%), Point72 Asset Management L.P. (1.73%) and BlackRock Inc. (1.50%). View institutional ownership trends. How do I buy shares of Zura Bio? Shares of ZURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Zura Bio's stock price today? One share of ZURA stock can currently be purchased for approximately $6.70. How much money does Zura Bio make? Zura Bio (NASDAQ:ZURA) has a market capitalization of $288.70 million. How can I contact Zura Bio? Zura Bio's mailing address is C/O Maples Corporate Services Limited, Po Box 309 Ugland House, Grand Cayman KY1-11. The company can be reached via phone at 858-247-0520 or via email at annemarie.fields@sternir.com. This page (NASDAQ:ZURA) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.